The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of body mass index (BMI) on clinical and toxicity outcomes in patients with relapsed metastatic germ-cell tumor (GCT) undergoing high-dose chemotherapy (HDCT) with peripheral blood stem cell transplant (PBSCT).
 
Ahmed Bilal Khalid
No Relationships to Disclose
 
Phillip Pham
No Relationships to Disclose
 
Rebecca Hassoun
No Relationships to Disclose
 
Sandra K. Althouse
No Relationships to Disclose
 
Rafat Abonour
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Janssen Oncology; Takeda
Research Funding - Janssen (Inst)
 
Mohammad Issam Abu Zaid
Stock and Other Ownership Interests - Pieris Pharmaceuticals
Consulting or Advisory Role - Osmium Health; Syndax
Research Funding - AlloVir (Inst); Incyte (Inst); Janssen (Inst); Pharmacyclics (Inst); Syndax (Inst)
 
Nasser H. Hanna
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck KGaA (Inst)
 
Nabil Adra
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol Myers Squibb Foundation; Bristol Myers Squibb Foundation; Exelixis; Merck; Sanofi
Research Funding - Exelixis (Inst); Genentech (Inst); Merck (Inst); Natera (Inst)
 
Lawrence H. Einhorn
Stock and Other Ownership Interests - Amgen
 
Jennifer King
No Relationships to Disclose